Real-world comparison of palbociclib, abemaciclib, and dalpiciclib as first-line treatments for Chinese HR+/HER2−metastatic breast cancer patients: a multicenter study (YOUNGBC-28).

Autor: Chen, Yifan, Xie, Yizhao, Sang, Die, Xie, Ning, Han, Xinhua, Zhao, Yanxia, Li, Juanjuan, Yue, Jian, Yuan, Peng, Wang, Biyun

Publikováno v: Therapeutic Advances in Medical Oncology; 12/17/2024, p1-21, 21p

Circulating soluble form of LR11, a regulator of smooth muscle cell migration, is a novel marker for intima-media thickness of carotid arteries in type 2 diabetes

Autor: Jin, Wenlong, Jiang, Meizi, Han, Xinhua, Han, Xuehua, Murano, Takeyoshi, Hiruta, Nobuyuki, Ebinuma, Hiroyuki, Piao, Lianshan, Schneider, Wolfgang J., Bujo, Hideaki

Publikováno v: In Clinica Chimica Acta 1 June 2016 457:137-141

Genetic dissection of the variation expression of Gsto1 in mouse hippocampus

Autor: Han, Xinhua, Chen, Ying, Ciobanu, Daniel C., Lu, Lu, Wang, Xiaodong

Publikováno v: In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2010 6(4) Supplement:S377-S378

Real-world comparison of palbociclib, abemaciclib, and dalpiciclib as first-line treatments for Chinese HR+/HER2-metastatic breast cancer patients: a multicenter study (YOUNGBC-28).

Autor: Chen Y; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Xie Y; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Sang D; Department of Medical Oncology, Sanhuan Cancer Hospital, Beijing, China., Xie N; Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital, Changsha, China., Han X; Department of Oncology, The First Affiliated Hospital of University of Science and Technology of China, University of Science and Technology of China, Hefei, China., Zhao Y; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Li J; Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, China., Yue J; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Yuan P; Department of VIP Medical Oncology, National Cancer Center, Tumor Hospital of the Chinese Academy of Medical Sciences, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China., Wang B; Department of Medical Oncology, Fudan University Shanghai Cancer Center, 270 Dongan Road, Xuhui District, Shanghai 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, 130 Dongan Road, Xuhui District, Shanghai 200032, China.

Publikováno v: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2024 Dec 17; Vol. 16, pp. 17588359241302018. Date of Electronic Publication: 2024 Dec 17 (Print Publication: 2024).